Prince Pharmaceutical Co., Ltd.
6935
Rank in Stocks
#24584
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Share Price
$0.85661329
Last synced: 2026-11-10
Market Cap
$32.05M
Change (1 day)
4.66%
Change (1 year)
-10.76%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Prince Pharmaceutical Co., Ltd. (6935)
Category
Healthcare
Operating Margin for Prince Pharmaceutical Co., Ltd. (6935)
Operating Margin as of November 2026 TTM: 12.37%
According to Prince Pharmaceutical Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 12.37%. At the end of 2025 the company had an operating margin of 10.50%.
Operating Margin history for Prince Pharmaceutical Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.37% | 17.81% |
| 2025 | 10.50% | -246.85% |
| 2024 | -7.15% | -309.68% |
| 2023 | 3.41% | -64.18% |
| 2022 | 9.52% | -3,908.00% |
| 2021 | -0.25% | -98.53% |
| 2020 | -17.00% | 355.76% |
| 2019 | -3.73% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.43% |
DE
|
|
| 19.68% | -98.41% |
DE
|
|
| 13.26% | -98.93% |
JP
|
|
| 17.08% | -98.62% |
CH
|
|
| 14.92% | -98.79% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Prince Pharmaceutical Co., Ltd.'s operating margin
What is Prince Pharmaceutical Co., Ltd.'s operating margin?
Prince Pharmaceutical Co., Ltd.'s operating margin is 12.37%, as of Nov 2026.
What was Prince Pharmaceutical Co., Ltd.'s operating margin in 2025?
In 2025, Prince Pharmaceutical Co., Ltd.'s operating margin was 10.50%, compared with -7.15% in 2024.
How has Prince Pharmaceutical Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Prince Pharmaceutical Co., Ltd.'s operating margin was highest in 2025 (10.50%) and lowest in 2020 (-17.00%).
How does Prince Pharmaceutical Co., Ltd.'s operating margin compare with similar companies?
Prince Pharmaceutical Co., Ltd.'s operating margin (12.37%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.